Le Lézard
Classified in: Science and technology
Subjects: Photo/Multimedia, Personnel

X1 Appoints Legal Technology Pioneer Rob Lekowski as Chief Revenue Officer


X1®, the global leader in index-in-place data discovery software for legal, compliance, investigations and productivity, today announced the appointment of Rob Lekowski as the company's new Chief Revenue Officer. As CRO, he will apply his extensive industry expertise to further accelerate growth of X1's data discovery solutions, expand and enhance value for customers and lead X1's sales strategy and team.

Rob Lekowski brings over 20 years of combined legal, eDiscovery and investigations technology expertise to X1, having previously held senior positions at several innovative companies in the eDiscovery space. "Rob is a pioneer and highly respected leader in the eDiscovery and legal industry, " said Larry Gill, Chief Executive Officer at X1. "We are extremely pleased to welcome Rob to the X1 team. Rob's large-scale domain expertise, known ability to drive exponential growth, and in-depth leadership skills driving top performers will help further expand X1's patented technology and industry-leading eDiscovery software solutions globally."

Rob's proven practices on building people, process and technology has consistently ignited significant growth with every organization he has worked with. Prior to joining X1, he led strategic sales efforts and consultancy services for organizations in the eDiscovery industry and successfully drove revenue increase with ESI Analyst (Acquired by CloudNine), DSi/Legility (Acquired by Consilio), Recommind, Inc. (Acquired by OpenText) and Fios, Inc. (Acquired by DTI). Rob has a Bachelor of Science degree in industrial management and engineering from Purdue University.

"I am thrilled to join X1 to continue escalating growth with this highly accomplished team and its industry-differentiating solutions," said Rob. "X1's unique index-in-place search and collection technology enables you to perform lightning-fast, federated, and highly targeted, search and collection of on-premise and cloud-based data sources. The ability to deploy this technology across the full Microsoft 365 suite (Teams, OneDrive, SharePoint, and Mail), as well as file-shares and traditional data sources, and then only collect what you need is a game changer. I am elated to join the X1 team and help champion such a revolutionary approach to data discovery."

About X1

X1 is the global leader in remote preservation and collection software. With more than 600,000 users in 20,000 different organizations globally, X1 solutions address our clients' and users' mission-critical needs every day. Please contact X1 at [email protected] or visit www.x1.com for more information. ¹U.S. Patents No. 7,496,559, 7,945,914, 8,019,741, 8,498,977, 8,856,093, 9,659,058, 10,346,550, 11,238,022 and 10,552,490.


These press releases may also interest you

at 09:05
Smart Meter, the leading supplier of Cellular Remote Patient Monitoring (RPM)tm solutions, has introduced a new version of the iGlucose, its patented cellular-connected glucose meter used by over 200,000 people with diabetes since 2019. The...

at 09:05
F5 announced that it has been singled out as a visionary in API security for its F5 Distributed Cloud Web App and API Protection (WAAP) in Enterprise Management Associates' Vendor Vision 2024 report. The report highlights "must see" security...

at 08:05
GE HealthCare today unveiled SIGNA MAGNUS, an FDA 510(k) pending head-only magnetic resonance (MR) scanner designed to explore advancements in neuroscience, which have been restricted by the performance limitations of conventional whole-body MR...

at 08:00
Gateway Fiber's high-speed 100% fiber internet is branching out to...

at 02:34
Elbit Systems Ltd.  ("Elbit Systems" or the "Company") announced today that it was awarded an initial contract of approximately $37 million to supply Iron Fist Active Protection Systems (APS) to General Dynamics Ordnance and Tactical Systems...

4 mai 2024
UroGen Pharma Ltd. , a biotech company dedicated to developing and commercializing innovative solutions that treat urothelial and specialty cancers, today announced results from a new analysis of the ATLAS trial, which estimates using Kaplan Meier...



News published on and distributed by: